Dual orexin receptor antagonists (DORAs), a class of drugs approved to treat insomnia, may also be effective for rapid eye movement sleep behavior disorder (RBD), a new study suggests. About 3 million ...
Please provide your email address to receive an email when new articles are posted on . The Syn-One Test detected P-SYN presence in 75% of study participants during baseline evaluations. P-SYN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback